title: Biochemical Identification of Vitamin B12 Deficiency in a Medical Office.
abstract: BACKGROUND
  A vitamin B12 deficiency can be an underlying cause or a deteriorating factor in several diseases. Nevertheless, early identification of such a deficiency remains a problem. Holotranscobalamin (HTC) is presently considered to be the gold standard. We tested the predictive power of other B12 parameters by comparing them with HTC.
  
  
  METHODS
  The blood of 77 patients from a medical office was tested for HTC, total B12 (CLIA [chemiluminescent immunoassay] and MTP [microbiological test with microtitre plates]), MMA (methylmalonic acid), HCY (homocysteine), and MCV (mean cell volume). The parameters were correlated and sensitivity, specificity, PPV (positive predictive value), NPV (negative predictive value), LR+ (positive likelihood ratio), and LR- (negative likelihood ratio) in comparison to HTC were determined. A ROC analysis was also performed.
  
  
  RESULTS
  At a cutoff value of 35 pmol/L for HTC, the total B12 CLIA (cutoff 211 ng/L) qualified 53% of individuals as having a B12 deficiency. The total B12 MTP (cutoff 288 ng/L) classified 71% as having a B12 deficiency. Specificity was similar in both cases (CLIA, 93%; MTP, 95%). With a cutoff value of 10 µmol/L for homocysteine, the best negative prediction was achieved. MVA has a low sensitivity (41%) and a high specificity (90%). Based on the ROC analysis, which indicated superiority of the B12-MTP, the reference levels of B12-CLIA and B12-MTP were raised to 304 and 368 ng/L, respectively. Thus, a probable B12 deficiency was identified in 94% of cases with either method and with a comparable specificity.
  
  
  CONCLUSIONS
  If total B12 is applied to identify B12 deficiency, the cutoff values should be elevated to 304 (B12-CLIA) and 368 ng/L (B12-MTP) to improve the predictive power. The negative-predictive power of HCY can be useful in daily routine. HTC has a broad grey area of uncertainty and MMA should only be applied as a confirmatory test.
authors: Joachim
authors: J
authors: Schwarz
authors: Eduard
authors: E
authors: Morstadt
authors: Andreas
authors: A
authors: Dura
authors: Karl Florian
authors: KF
authors: Wintgens
authors: Katarina
authors: K
authors: Hartmann
authors: Franz Paul
authors: FP
authors: Armbruster
authors: Thomas
authors: T
authors: Dschietzig
mesh_terms: D000553:Ambulatory Care; D019540:Area Under Curve; D015415:Biomarkers / Q000097:blood; D003430:Cross-Sectional Studies; D042241:Early Diagnosis; D006710:Homocysteine / Q000097:blood; D006801:Humans; D007118:Immunoassay; D008163:Luminescent Measurements; D008297:Male; D008764:Methylmalonic Acid / Q000097:blood; D008875:Middle Aged; D009819:Office Visits; D011237:Predictive Value of Tests; D012372:ROC Curve; D014155:Transcobalamins / Q000032:analysis; D014805:Vitamin B 12 / Q000097:blood*; D014806:Vitamin B 12 Deficiency / Q000097:blood / Q000175:diagnosis*
chemical_list: D015415:Biomarkers; D014155:Transcobalamins; D006710:Homocysteine; D008764:Methylmalonic Acid; D014805:Vitamin B 12